学术探索
学术期刊
新闻热点
数据分析
智能评审

CYCLOPHOSPHAMIDE IN SOLID TUMORS

被引：29
作者：
CARTER, SK
LIVINGSTON, RB
机构：
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20014
[2] MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX
来源：
CANCER TREATMENT REVIEWS | 1975年 / 2卷 / 04期
关键词：
D O I：
10.1016/S0305-7372(75)80010-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：295 / 322
页数：28
相关论文
共 137 条
[81]  
Higgins G A, 1969, J Surg Oncol, V1, P221, DOI 10.1002/jso.2930010304
[82]  
HOEST H, 1973, CANCER CHEMOTHER REP, V4, P161
[83]  
HRESHCHYSHYN M M, 1973, Gynecologic Oncology, V1, P220, DOI 10.1016/0090-8258(73)90014-0
[84]   COMPARATIVE TOXICITY ON LEUKOCYTES AND PLATELETS OF 2 REGIMENS OF CCNU - RELATIONSHIP BETWEEN MAXIMUM DOSE AND OPTIMUM DOSE [J].
ISRAEL, L ;
CHAHINIAN, P .
EUROPEAN JOURNAL OF CANCER, 1973, 9 (11-1) :799-802
[85]   MECHLORETHAMINE HCL AND CYCLOPHOSPHAMIDE IN TREATMENT OF HODGKINS DISEASE AND LYMPHOMAS [J].
JACOBS, EM ;
PETERS, FC ;
LUCE, JK ;
ZIPPIN, C ;
WOOD, DA .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 203 (06) :392-&
[86]  
JOHNSON CE, 1972, AM J ROENTGENOL, V114, P136
[87]  
JOHNSON FD, 1971, CANCER-AM CANCER SOC, V27, P1306, DOI 10.1002/1097-0142(197106)27:6<1306::AID-CNCR2820270605>3.0.CO
[88]  
2-R
[89]   URINARY-BLADDER FIBROSIS AND TELANGIECTASIA ASSOCIATED WITH LONG-TERM CYCLOPHOSPHAMIDE THERAPY [J].
JOHNSON, WW ;
MEADOWS, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 284 (06) :290-&
[90]  
KAUNG DT, 1974, CANCER CHEMOTH REP 1, V58, P359
45678910111213